Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 04/10/20121 min de lecture
New Animal Drugs; Change of Sponsor's Address; Monensin; Spinosad; Tilmicosin
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) during August 2012 and to reflect a change of sponsor's address for Baxter Healthcare Corp. FDA is also informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →